Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Adrienne H Long und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, Cali…. Hauptthemen laut MEDLINE: Agammaglobulinemia, Immunotherapy, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases, NIH HHS, American Academy of Allergy Asthma & Immunology.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Hypogammaglobulinemia is a well‐defined risk factor for infection. B‐cell‐directed immunotherapies given in addition to conventional chemotherapy are now core elements of effective therapy for children with B lymphoid malignancies. These therapies are associated with depletion of normal B cells and consequent hypogammaglobulinemia. This review summarizes the current state of knowledge regarding the mechanism, incidence, and clinical outcomes related to hypogammaglobulinemia in children with mature B‐cell non‐Hodgkin lymphoma and B‐cell acute lymphoblastic leukemia, as well as provides practical guidance for laboratory monitoring and considerations for immunoglobulin replacement therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.
- Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID-Profile: Adrienne H Long, Sarah Alexander
Förderung
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- American Academy of Allergy Asthma & Immunology
- National Institutes of Health
Zitieren
APA
Long, A. H., Aftandilian, C., Barmettler, S., & Alexander, S. (2025). Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31779
Vancouver
Long AH, Aftandilian C, Barmettler S, Alexander S. Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31779
BibTeX
@article{Long2025,
author = {Long, Adrienne H and Aftandilian, Catherine and Barmettler, Sara and Alexander, Sarah},
title = {Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31779}
}
EUVIMED